Login / Signup

Evaluation of 2 breast cancer risk models in a benign breast disease cohort.

Ryan D FrankStacey J WinhamRobert A VierkantMarlene H FrostDerek C RadiskyKarthik GhoshKathleen R BrandtMark E ShermanDaniel W VisscherLynn C HartmannAmylou C DueckCeline M Vachon
Published in: Cancer (2018)
The BCSC and BBD-BC models were validated in the Mayo BBD cohort, although their performance differed by 5-year risk versus 10-year risk. Further enhancement of these models is needed to provide accurate BC risk estimates for women with BBD.
Keyphrases
  • breast cancer risk
  • mass spectrometry